Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tip of the year
ITUP
The CEO says it's a $300 stock.
According to my calculations, it's between a $100 and a $500 stock, depending on
1) how succesful they are with their business plan
2) how the market values it
$SING SinglePoint Inc. (OTC:SING) Subsidiary Direct Solar of America, Signs First-of-Its-Kind Agreement with Soligent Distribution LLC, the Nation's Largest Solar Materials Supplier
http://www.releasewire.com/press-releases/singlepoint-inc-otcsing-subsidiary-direct-solar-america-signs-1314039.htm#
$MDXL President of Health Karma Gets Recognized as an Honoree for the First Annual Excellence in Healthcare Awards by South Florida Business & Wealth (SFBW)
$MDXL 600k Float and thin ask. Company developing HealthKarma launching fully in November
Latest News On $MDXL showing good stuff going on
Well the RVVTF warrants were not like Toxic Con-Debt conversion. And we know the money was going to goo use that is a 10 year wait for drug trial results. This one could blow up fast this year, from what I have read, and what I know (RA-Drug-COVID19 science....)
The chart is awesome for e buy in today.
Thanks!!!!
Folks I bought $BABL last week and it is screaming today.
Made my first buy of $RVVTF a Covid19 drug trial bet an hour ago, It is, I think a solid low risk mega high reward COVID19 drug play, with drugs approved and in Use in Korea and Japan for RA, that may soon have approvals for use with CODID19 as well.
Keep in Mind Remdesivir (Gilead) is also an RA drug being used widely in the US now for CODID19 patients. Gilead has 100times the MC of RVVTF. This has nuclear price explosion news potential.
NDTP is also a super strong buy, 100 bagger upside any day, waiting for the mother of all SEC filings, an SEC S-1/1-A filing with the entire Biotech R/M Public birth of private Biotech.
Thanks PB, I am bringing buyers, at the bid...
RVVTF In the past 6 months the warrants they issue raising money for the phase 3 trials that stop PPS moving higher. Good thing the warrants dilution finally come to an end.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157318812
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158113017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157301529
https://microcapdaily.com/the-exciting-story-of-bucillamine-revive-therapeutics-ltd-otcmkts-rvvtf/127931/
Check out $MDXL Latest News! Big things going on
Awesome. I got slammed with 4 illnesses at once in 2014. MD's were clueless for months. Nearly killed me. But what does not kill you makes you stronger.
LOL
Dr. Ecomike figured it out. Medical tests confirmed my Theory...
Take a hard look at $NDTP
The website just went live at the Float is locked at 290K shares for 12+ months. Explosive billion dollar Biotech birth like we have never seen. See you on the NDTP board? Check the Ibox for the details
https://www.ndtpharma.com/
My earlier DD on it:
https://ccabiotech.blogspot.com/p/patent.html
https://ccabiotech.blogspot.com/p/members.html
https://ccabiotech.blogspot.com
https://ccabiotech.blogspot.com/home
http://grantome.com/grant/NIH/R01-NS069629-05
Dr Cohen Grants TBI Huge find!!! of mine (I literally spent 400 hours and went through 500,000 pages of research papers and patents to find the key guy and his papers):
https://www.researchgate.net/publication/322275261_Dietary_therapy_restores_glutamatergic_input_to_orexinhypocretin_neurons_after_traumatic_brain_injury_in_mice
$TDOC $NVS
$GNBT $AMGN $MRK $PFE $ABT $JNJ $BMY $QDEL $GSK $ABBV $LLY $CELG $BIIB $REGN $NVO $GILD $RHHBY $VRTX
$CPWY $AVXL $CGC $HEMP $MJNA $HEXO $TGODF $KSHB $CBDS $HRVSF $EMHTF $OGI $ALEAF $CBWTF $SPRWF $VPOR $GBLX $ERBB $LXRP $TURV $KAYS $MNTR $CNAB $AMMJ $KSHB $MJNE $NDEV $CVSI $HLSPY #Forex #NASDAQ #ICE #ETF
Ecomike nice to hear from you again! Glad to hear your doing well and will be following your board.
If you have any key details please share then.
Thanks.
MediXall Group $MDXL is one strong Healthcare company on the rise
Things always take longer than expected.
Buy PCTL. Revenues are going through the roof. They should report Q2 results any day now.
You can read a good summary if you read the posts on the China Unlimited Board of the past few days.
The old MILV stock, now $NDTP Biotech, the website
www.ndtpharma.com
Just went live.
SEC filings could drop tonight.
FOMO time is upon us
I'm buying the pullback on VMNT
Expecting big news soon
LOL, Check out $NDTP, its about to bust loose and pass the Microsoft share price, once the SEC filling drops. Biotech birth to shell and almost know knows about it yet.
I'm all about VMNT at the moment bud
I am expecting an SEC 1-A underwritten offering and up list to NYSE overnight, adding $40 Mil dollars to the cash balance in the R/M and SEC going current filling process that re-registers the shares with the SEC.
Three of the Principles run and have run NYSE and NASDAQ billion dollar firms. Look over the story here:
https://ccabiotech.blogspot.com/p/members.html
Read up on Larry Kubin, Mathias (The Carlyl Group on Nasdaq) and Stuart(?) Yarbrough (CISSION just bought for Billions).
Thanks X-ray07 keep us updated please, sounds interesting. $TREP
Set an alert to watch for an SEC filing on NDTP. When it drops it will be SEC current, and you can buy it, as it will likely uplist to NYSE over night. Right now it has 15-12g non reporting CE-Caveat Emptor block unless you have a Penny stock broker in the US like CSchwab.
Many of us has target estimates of 100 to 300 $$ the first year that filing drops as the float is only 290,000 shares and the OS is only 450,000 with no debt and no new retail shares possible.
Best pick I have found in 40 years.
$NDTP , we know from the shareholder letter, the Nevada SOS updates, 12 years of fees paid to the Nevada SOS and the company naming Hovis the CEO/Director in Late May, and from the OTCmarkets updates who the CEO is, James Hovis, the same person Running CCA, LLC and the attorney doing the SEC package, S-1/1-A, and all of those tell us the Private Biotech CCA, LLC is merging with the old Milv (now known as NDTP ) shell, already renamed NDTP for Nano Delivery Technology Pharmaceuticals Inc.
We know who the founders (2013), founding shareholders of CCA, LLC are, we know they are and have been Building a Billion dollar Biotech, and we know they have been been partnered with the University of Pennsylvania's Medical University Research Hospital's Traumatic Brain Injury teams and they have been successfully testing the soon to be NDTP, BBB-Blood Brain Barrier crossing nano-particle complex (liposome tech) oral IV drink line capable non drug technology that could hit the streets running as drink line, meaning almost immediate revenue.
And Licensing to big Biotechs for use to carry Rx drugs, already approved, for delivery to the brain.....
The float is only 290,000 shares. At $3/share that is $870,000 float,
The news I expect to see will reveal a billion dollar Biotech and billion dollar drink line IMHO.
Going from $870,000 to 1 Billion dollars is a 1000X jump! That means $3/share could see $3000/share.
But we also know the CCA, LLC folks will get shares, and any cash raised (If not already done with CCA, LLC shares ) will add to the OS.
So assume the OS goes from 450,000 to 4,500,000 shhares, a 10X increase.
Then $3000/share becomes a $300/share potential price target
Massive upside potential, and almost zero down side potential.
The stock already traded at $10 to $10.60/share twice.
Thanks. I checked with my broker, I can buy the stock. But no money currently. Perhaps later.
Thanks for sharing on my board Dutch.
NDTP (was MILV) is hours to days away now from the Biotech R/M SEC filings IMHO. The last step that turns the lights on.
Last chance to get in before the rocket ride.
Float lock of 290,000 shares, AS 450K shares biotech birth inbound known to be coming.
I expect an SEC S-1 at the Min, or an SEC 1-A with 40 Mil $$$ cash raise and immediate uplist to the NYSE
$100 to $300/share targets have been estimated based my DD of the technology they disclosed in a 2016 SEC filing.
Details on the history of the private Biotech R/M into it:
https://ccabiotech.blogspot.com/p/patent.html
https://ccabiotech.blogspot.com/p/members.html
https://ccabiotech.blogspot.com
https://ccabiotech.blogspot.com/home
http://grantome.com/grant/NIH/R01-NS069629-05
Dr Cohen Grants TBI Huge find!!!
https://www.researchgate.net/publication/322275261_Dietary_therapy_restores_glutamatergic_input_to_orexinhypocretin_neurons_after_traumatic_brain_injury_in_mice
$MILV is now $NDTP and is now Penny Stock exempt per OTC. I saw signs the Website was being worked on, and it starts to trade as $NDTP on Monday morning.
Last trade was an 11 year high Friday, at $10.60/share
(.0106 pre split basis)
The MILV train has left the station and is Nasdaq Bound as $NDTP as was foretold by the sages of MILV.
OTC CE Pink pigs can fly people!!!
They are super rare critters. I found one, 2 times now.
TREP worth take a look at folks...
Posted updated DD..
Company has been making net profits for the last 16 quarters and is close to posting 2018 and 2019 audited financials
Paying much attention to MBS REITS lately. Check on MILV daily and can easily add along with QTMM and GNBT.
We have missed you in my discord room. I exorcised all the daemons and devils, LOL.
It is an open stock board board now
Yes, holding and looking forward to filings.
Seeing some solid bids and buying and ask slapping on $MILV last 3 days.
You win the Lottery again?
LOL
I also had a painful experience. I had Nasdaq put options that expired March 6. I could see the Corona mess coming since late January.
Nothing could kill the market. And I knew I was being squeezed. But when the market ended green after a profit warning from Apple, in late february, I just had to give up. It was the right decision.
One day later Goldman Sachs comes out with a statement saying the corona virus could be a problem. Geez... what a surprise. And now the markets can go down suddenly. Followed by many deaths in Italy the following day, so the markets worldwide collapse, well before March 6.
Ugh. And the lies from Trump and all those other idiots, that kept the market high. Yuck.
Anyway, get yourself a position in HERB. All we need is one announcement. I just can't tell you when.
When GE bought Alstom Power they slow-fucked-MVTG and never honored the Alstom Power agreement that MVTG had with Alstom Power.
GE was already broke, and killed MVTG and it's Tech/patents to protect what was left of GE's dying Fossil Fuel business.
Had GE not bought Alstom Power I would have made millions of $$$s of MVTG.
MVTG was taken over by Spectrum and 3 white collar crooks the SEC is investigating. Spectrum finished off killing MVTG. but MVTG Mantra Energy and its patents went private out the back door and has been dark ever since.
Long story. I was up $500,000 on MVTG Summer of 2014 in paper gains.
Thanks RD, nice to see many of us are still alive and kicking.
Thanks for sharing your picks here. Keep it coming!
Time to wake this board back up.
MILV and HERB have roughly the same market cap.
Except HERB has a little more cash
Each to their own
Caveat Emptor, whooooooo, my kinda stock
Time for a one-two punch perhaps. In our favor.
No longer pursuing MVTG (Spectrum), eh?
Start-ups are a bitch. I know all about it....
Cash $717M as per appraisal firm
Hey Mike, folks.
That's the title of my sticky on the HERB message board. And that's the sticky that got us some attention lately.
HERB has a $3M market cap and is trading at 2 friggin cents.
Mike will tell you that I am no fool. And I am not
I was inviting some big whales over the weekend and since we ran into each other lately I thought, why not visit this message board.
The case,
1) Yes, they should be sitting on $700M+ in cash
2) 83% owned by the Gansu provincial government, so a CEO rip-off is not going to happen
3) It's a non-reporting Chinese pinky but I'm expecting either a merger with the sister company in Shanghai, a buyout or going private offer, or even a huge dividend if the state needs money due to Corona.
That is all. You just need a very small position for an exceptional ROI.
GL, and stay healthy
MILV Yeeesss Found a 2 Nice REITs insides buying they went on heavy sale last week NRZ CIM / Money Injected Great place to Park Money in a dt.
Many 10K 30K late today slaps lately.
They need to get the OTC straightened Out. Foremost Im sure you understand this probably better than myself.
Have you been on contact at all injecting any ideas or suggestions that they also have I-Hub's eyeballs and the MLIV Army lol.
Once the dust turns into silver that wound be sweet,
http://stockcharts.com/c-sc/sc?s=NRZ&p=D&st=2013-05-02&en=(today)&i=t36275682205&r=1368753670695
MILV is kickin it added over 500K shares yesterday. This helps visibility. Would you believe I bought BAC in the upper market and cut way back on SPCE, DEAC and INSG so I still have some Margin. Crazy Market. Too Bad I missed AIM and congrats. 9K in GNBT
Solar, have you seen AIM in the aftermarket?? This is simply amazing. Up 300% today, including the after hours rampage. Thanks a million times over.
One of these days, MILV will have this kind of move. Not far off in my opinion
AIM: solar_express, I think I've thanked you 2 or 3 times already, but my god, "thanks" isn't really enough. I'm up almost 600%! I've been profit taking along the way, and today sold a nice chunk at $5.50 (at which point it promptly surged higher lol). Do you like GNBT more than AIM? I did, and had bought more GNBT than AIM. Thinking about putting some of that profit into getting more GNBT, but was curious to get your take.
Thanks again my friend. This has been unreal
Headline: GNBT Generex Receives Contract from Four Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines
GNBT is Getting Seriously Interesting Turnaround OTC Biotech Company with lots of subs. Besides their turnaround and S1 (2 NASDAQ uplistings) the Corona thing just landed on their lap. Read on
Generex has Funding, Covad/19 Chinese Contract, Royalties, Recent Articles and WHO Recognition. The CHINESE SIGN A CONTRACT with GENEREX THIS IS HUGE when you sit back and realize the only thing holding this back is "what you tell me" This company is being looked at as an OTC Shell LOL. Its a lot more than people realize with many subs. This shell will burst onto the NASDAQ Times 2 Leading with NGIO. Fact: Covid/19 plays have been runners in recent days. You know what else I hope Generex can lead the way to make an effective vaccine. This is some serious sh"t.
LOOKS SOLID for NGIO: Our subsidiary NuGenerex Immuno-Oncology (NGIO) "Future NASDAQ Listing" has developed Ii-Key peptide vaccines against several potentially pandemic viruses, including bird flu, swine, flu, HIV, and a previous coronavirus, SARS. This wealth of experience has enabled us to develop a standardized protocol for rapid vaccine development, so we are positioned to respond in the event of a new, emerging pathogen. Our partners in China have recognized the power of our Ii-Key platform and have delivered this contract to establish a collaboration to combat the COVID-19 epidemic, and we are excited to begin the work.”
Worth Lot more than 80 cents worth. Fuzzy rapid numbers upward may come into play very soon.
GNBT Generex Receives Contract from Four Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154104505
$MILV Thank you for posting that update to the OTCMarkets homepage for MILV. Saw that they updated their bio page with the new owners of the ticker and the website: ndtpharma.com
I like that they are using the shorter URL. It's much cleaner than the longer bulky ones. I imagine they will make it so those URLs automatically push to the main website.
Only a matter of time before the hearing March 12, 2020 for termination.
$MILV is showing off today up 12% on last night's bread crumb news while the rest of world stocks are getting plundered and bulldozed.
Broke out into the 6's today.
New CEO, website and address and phone number update on OTCmarkets for MILV showed up late in the day yesterday.
Ask slap fest underway today
Accumulating a little of $DGIF on financials uploaded and name changed to D7 Enterprises something might be brewing
Been reading your GNBT posts all morning, as well as all the others on the board. Really interesting investment, and no doubt could explode higher if this goes well. I'm hoping ANYONE has a vaccine or cure for it, as it's fast becoming a terrifying situation. Would be great if it's GNBT or AIM of course :)
Thanks again Solar!
Generex Biotechnology Investing DD 2020
1) The CEO Joe Moscato is a marketing guy and he knows how to get everyone to see the big picture and to take long term views. Even if it means taking less pay now for rewards later. Including himself. No big fat salary for Joe now. In fact he has pretty much deferred any salary. What CEO does that?
2) GNBT filed an S-1 registration with the SEC with the future plans all noted. When the S-1 gets approved they have financing approved for a minimum of $40M to be used if needed. Think of it as a line of credit. The S-1 could be approved ANY day.
3) The financing allows them to purchase a majority interest privately held company named Altucell who may have a treatment which may cure Type 1 Diabetes. This companies research is fairly advanced and additional trials are about ready to go once funding arrives. Why?
from Generex:
"as part of our due diligence
process, we pinpointed specific, comparable deals that validate the huge value of the
ALTuCELL acquisition, as evidenced by the recently announced purchase of Semma
Therapeutics by Vertex Pharmaceuticals for close to a billion dollars."
4) Generex is spinning off NGIO and it should be trading on the Nazdaq within a few weeks. It will be owned by Generex shareholders as we have been awarded dividend shares and ~70% by Generex. NGIO has the coronavirus vaccine to develop and a vaccine it is currently studying for breast cancer. Prostate research is underway as well. Other research is pending the new funding. Regarding number 4, I should have mentioned Merck. No doubt you all know about Keytruda being huge in cancer. The Generex/NGIO breast cancer study is a combo of NGIO's AE37 and Merck's Keytruda.
5) One of Generex's subs has a number of test kits for various ailments is working on a coronavirus test kit NOW.
6) Another sub, Olaregen has a wound care product being sold in the VA system and producing significant NEW revenue for Generex as of the last 3 months.
7) It was just announced two of the other subs have had a 400% increse in sales of their medical products recently
Over the next few day I will tell you about the MSO, HMO,Type 2 diabetes treatment and more.
Count yourselves lucky to be here now just before the good stuff is going to come together. Flippers will look back and regret having sold quite soon.
Did I mention Generex has already filed for UPLISTING ON THE NAZDAQ for GNBT? Waiting on the S-1 to be approved and the financing to be put to work.
I have followed the company for awile not your ave OTC they are for real. You will do quite well. I have been holding 5K shares and pleasantly surprised with the headline. I plan to buy more 2morrow. Ck out my posts on GNBT and docj sticky.
Thanks Solar. Haven't had much time to get on here today, but I saw your post and bought GNBT at $1.13. Might be the first time in my life I bought a stock that was already up 100% for the day lol. Yeah, definitely the first time I've done that actually. After your AIM call, I didnt even do any dd. I read your post and bought some. Didnt go in huge, based on both of the above things (up 100% for the day and no time to even dig into the company at all). If it goes up, great. If it goes down, I'll add more I think. Read a bit more on the company tonight and it seems like a great play, even after the gains.
You rock man. Thanks again
Followers
|
86
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3782
|
Created
|
08/02/13
|
Type
|
Premium
|
Moderator Ecomike | |||
Assistants maybethistime |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |